Not a good buy right now: the trend is decisively bearish (SMA_200 > SMA_20 > SMA_5) and momentum is still deteriorating (MACD histogram negative and expanding).
Although RSI_6 is extremely oversold (11.14) and could spark a short-lived bounce, price is trading below the first support (S1=2.32) in pre-market (2.31), increasing the odds of a continuation down toward S2=2.062.
Options positioning is mixed but leans cautious (high open-interest put/call), and implied volatility is extremely elevated—suggesting the market is pricing big moves, not stable upside.
Momentum: MACD histogram is -0.00769 and negatively expanding → downside momentum is strengthening, not stabilizing yet.
Oversold: RSI_6 = 11.139 (extremely oversold) → bounce risk is real, but oversold can persist in downtrends.
Levels: Pre-market 2.31 is slightly below S1=2.32 (broken support). Next downside level is S2=2.062. Upside rebound targets: Pivot 2.739, then R1 3.157.
Pattern-based forward look (provided): ~6.5% expected move potential over next week, but next-month bias is slightly negative (-2.85%), consistent with a weak broader trend.
Options Data
Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning/Sentiment: Open interest put/call ratio 2.18 (puts dominate OI) → investors are positioned defensively / hedged.
Near-term flow: Volume put/call ratio 0.44 → today’s traded volume skewed more to calls than puts (possible short-term bounce/speculation).
Volatility: 30D IV 122.09 with IV percentile 97.4 (very elevated) → options are pricing large moves; sentiment is uncertain/high-risk rather than confident bullish.
Activity: Today’s volume 756 vs 30D average surge (21.3x) and open interest elevated (todays OI 100,344; today vs OI avg 117.14) → unusually high derivatives attention.
Technical Summary
Sell
8
Buy
5
Positive Catalysts
can support a short-term bounce.
Neutral/Negative Catalysts
pre-market; failure to reclaim it quickly raises risk of a move toward S2 (2.062).
Financial Performance
Latest quarter: 2025/Q3.
Net income: 1,625,328; EPS: 0.05.
Reported YoY growth rates show 0.00% and revenue listed as 0 (data quality/early-stage/low-visibility financials implied). Based on the provided snapshot alone, there is no clear accelerating top-line growth signal to justify buying into a downtrend.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating trend or price target change data was provided, so there is no visible Wall Street consensus catalyst supporting an immediate buy.
With limited visibility on coverage/targets, the risk is that the stock trades primarily on technicals/positioning rather than fundamental re-rating.
Wall Street analysts forecast BRR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BRR is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast BRR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BRR is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
